Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

SUZHOU, China, May 26, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today anno...

2020-05-26 07:30 9432

China's medical rehabilitation market likely to see significant growth potential, five key sub-sectors identified, finds KPMG report

HONG KONG, May 25, 2020 /PRNewswire/ -- With increasing importance placed on medical rehabilitation, KPMG has identified five out of eleven rehabilitation sub-sectors with the highest potential in terms of their market attractiveness and market entry abilities. These are neurological rehabilitati...

2020-05-25 18:40 2547

New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks

- Not intended for UK and U.S. based media - Investigational evobrutinib is the first and only Bruton's Tyrosine Kinase inhibitor to demonstrate high and sustained efficacy through 108 weeks in clinical studies - No new safety signals identified in the 60 week open-label extension, consistent ...

2020-05-25 08:18 2202

HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China

SINGAPORE, May 25, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex 's AI-based stain-free digital pathology platform has long been established as a suitable tool for global clinical guidelines that outline the assessment, prevention and treatment of Chronic ...

2020-05-25 06:00 3415

HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China

Dr. Rajamannan Reports to Northwestern University, Chicago IL VP: COVID-19 Non-Compliance in Clinical Trials

COVID-19 - The letter to the VP for Research SHEBOYGAN, Wisconsin, May 22, 2020 /PRNewswire/ -- Most Sacred Heart of Jesus Cardiology and Valvular Institute Director Dr. Nalini Rajamannan, has submitted evidence in an open letter toNorthwestern University's Newly Minted Vice President for Resea...

2020-05-22 23:13 3606

MEDI FUTURES designated as "Global ICT Future Unicorn"

SEOUL, South Korea, May 22, 2020 /PRNewswire/ -- MEDI FUTURES, a biomedical ultrasound company, was designated by the Korean government as a "Global ICT Future Unicorn." MEDI FUTURES has been an active member of theBorn2Global Centre . MEDI F...

2020-05-22 16:15 3988

Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg inthe United States. Mayne Pharma received approval from the US Food and Drug Administration for its Abb...

2020-05-22 13:44 5638

Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport

TOKYO, May 22, 2020 /PRNewswire/ -- Nippon Express (UK) Co., Ltd. (hereinafter, "NEUK"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has been officially granted Wholesale Distribution Authorisation (WDA) and Good Distribution Practice (GDP) certification for its warehouse near L...

2020-05-22 13:00 1479

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. Under the terms of th...

2020-05-22 07:11 6454

Solve M.E. Announces Oved Amitay as President and Chief Executive Officer

Global Healthcare Industry Veteran Plans to Leverage Extensive Advocacy Experience, Rare Disease Expertise, and a History of Creating Important Public-Private Partnerships to Benefit ME/CFS Patients; Timing Could Not Be More Critical LOS ANGELES, May 22, 2020 /PRNewswire/ -- Solve M.E., the lead...

2020-05-22 02:00 2696

Solve M.E. Announces Oved Amitay as President and Chief Executive Officer

Frost & Sullivan Analyzes the Future of Adhesion Prevention Products in the US and EU5

Film-type APP is expected to have the largest share of the total APP market, followed by gel-based products SANTA CLARA, California, May 21, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities for Adhesion Prevention Products Market in US and EU5, Forecast to 2024, predi...

2020-05-21 23:50 2710

Frost & Sullivan Analyzes the Future of Adhesion Prevention Products in the US and EU5

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

PneumoBlast™ Reduces Pathology and Lung Fluid Accumulation in Model of COVID-19 HOUSTON, May 21, 2020 /PRNewswire/ -- FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19. Mice immune systems were stimulate...

2020-05-21 22:03 2940

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

2020-05-21 22:03 2302

100+ Experts Identified Top Threats and Opportunities for Global Health Just Before COVID-19 Emerged as the First Test of the Medicines Supply Chain

New U.S. Pharmacopeia and MIT Center for Collective Intelligence report examines outlook for the future of medical breakthroughs ROCKVILLE, Md., May 21, 2020 /PRNewswire/ -- Just a few weeks before the first cases of COVID-19 were made public, a group of more than 100 leaders in health and medici...

2020-05-21 20:32 442

Ally Bridge Group Leads US$150 million Financing for Three U.S. Companies Amidst the COVID-19 Pandemic

NEW YORK and HONG KONG, May 21, 2020 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it led three investments in the U.S. -- two medtech and one telehealth -- in April, 2020 amidst the COVID-19 pandemic. Each of the three companies is ...

2020-05-21 20:00 9839

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme

SHANGHAI, GAITHERSBURG, Md. and SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medi...

2020-05-21 20:00 5849

Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

STOCKHOLM, May 21, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated...

2020-05-21 16:18 2255

Dr Ivan Puah, Medical Director Of Amaris B. Clinic, Observes Positive Correlation Between Stress, Weight Gain And Physical Body Pain

SINGAPORE, May 21, 2020 /PRNewswire/ -- The COVID-19 pandemic has disrupted the lives and livelihood of many people. It has caused insecurities, anxiety and a feeling of helplessness among those affected. All these and more increase stress levels and if not managed well can lead to a multitude...

2020-05-21 14:12 3955

Dr Ivan Puah, Medical Director Of Amaris B. Clinic, Observes Positive Correlation Between Stress, Weight Gain And Physical Body Pain

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

SEATTLE, May 21, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership withTakara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, wit...

2020-05-21 14:00 3646

Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purcha...

2020-05-21 12:00 14361

Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

1 ... 562 563 564565566 567 568 ... 608